An exaggerated blood pressure (BP) response to exercise predicts future cardiovascular risk. The mechanisms underlying exercise-induced hypertension remain unclear, although endothelial dysfunction and elevated arterial stiffness may contribute. Given the association between reductions in nitric oxide (NO) and vascular dysfunction, we sought to determine whether acute inhibition of NO synthase with N G -monomethyl-Larginine (L-NMMA) would lead to exaggerated BP responses to maximal exercise and attenuate exerciseinduced reductions in arterial stiffness. In 10 healthy subjects (31 ± 5 years), BP and heart rate (HR) were measured before, during and after an incremental cycling exercise test to determine maximal oxygen consumption (VO 2 max). Trials were performed with placebo (saline) or intravenous infusion of L-NMMA on separate days in a randomized, double-blind, crossover design. Central (aortic) and peripheral (femoral) arterial stiffness were assessed using pulse wave velocity (PWV). BP was increased with L-NMMA at rest and during sub-maximal exercise, but not at maximal exercise (mean BP 117±5 vs 118±8 mm Hg, saline vs L-NMMA, P40.05). Furthermore, L-NMMA had no influence on exercising HR or VO 2 max (Po0.05). Notably, aortic PWV was similarly increased after exercise with either saline or L-NMMA (Po0.05), whereas postexercise decreases in femoral PWV were attenuated with L-NMMA (Po0.05). Our findings suggest that NO is an important contributor to reductions in femoral artery stiffness after maximal exercise in healthy individuals. Furthermore, acute pharmacological inhibition of NO synthase causes augmented BP responses to sub-maximal exercise, but does not lead to exaggerated BP responses to maximal exercise or reduce maximal oxygen consumption.
Introduction
Cardiopulmonary exercise testing is a valuable clinical tool for the detection of coronary dysfunction and evaluation of functional capacity in patient populations. The clinical significance of blood pressure (BP) responses to exercise stress testing is now also gaining increased recognition. 1 Indeed, an exaggerated BP response to exercise is associated with an increased risk of future hypertension, 2, 3 stroke 4 and cardiovascular mortality 5, 6 in apparently normotensive individuals. However, the physiological mechanisms underlying such exaggerated exercise-induced BP responses in both patients and apparently healthy individuals remain unclear.
Recent studies have suggested that increased arterial stiffness causes not only elevation of resting BP, particularly systolic and pulse pressure, 7 but may also influence BP responses to exercise. 8 Previous work by our group and others have shown that pulse wave velocity (PWV), which is a measure of arterial stiffness, 9 is reduced in the exercising limbs after a bout of maximal 10 or sub-maximal 11, 12 exercise in healthy subjects. Notably, arterial stiffness is not only determined by the passive properties of the structural components of the vessel (that is, elastin and collagen crosslinking), but also changes in vascular tone and endothelial function. 13 Indeed, arterial stiffness is reduced by intraarterial infusion of the nitric oxide (NO) donor glyceryl trinitrate, but increased by blockade of NO synthase with N G -monomethyl-L-arginine (L-NMMA). 13 Intriguingly, recent work has shown a relationship between exaggerated BP responses to exercise and impaired endothelial responses to flow-mediated shear stress 14, 15 or pharmacologically stimulated NO release. 16 Furthermore, an impaired capacity for exercise-induced decreases in systemic vascular resistance has been reported in subjects with exaggerated BP responsiveness. 17 Taken together, these findings imply that NO and vascular tone are key factors in the functional regulation of arterial stiffness and hence may be an important determinant of the magnitude of the exercise-induced BP response.
Along with modifying the BP response to exercise, increased arterial stiffness can markedly influence cardiac performance during exercise. Indeed, in exercising dogs increased aortic stiffness exacerbates rises in systolic BP, imposes additional energetic demands on the heart and slows the rate of relaxation of the left ventricle. 18, 19 Hence reduced vascular NO and increased central arterial stiffness may indirectly impair cardiac performance during exercise in humans. Notably, NO is also known to have beneficial effects on active myocardial relaxation; 20 a priori, the positive lusitropic effects of NO are likely to become particularly important for maintenance of diastolic volume at high heart rates. 21 It is noteworthy that NO synthase inhibition with L-NMMA in anaesthetized dogs increases myocardial stiffness and impairs the preload-induced augmentation of cardiac output. 22 Together, these findings suggest that reductions in NO during exercise in humans may increase aortic stiffness, impair diastolic function and ultimately reduce maximal cardiac output and thus exercise capacity.
With this background in mind, this investigation was designed to test the hypothesis that acute inhibition of NO synthesis with L-NMMA in healthy subjects would attenuate exercise-induced reductions in peripheral and central arterial stiffness, cause exaggerated BP responses to sub-maximal and maximal exercise and reduce exercise capacity. To achieve this, the influence of an incremental maximal exercise test on BP responsiveness, arterial stiffness and exercise capacity was assessed after NO synthase inhibition in a randomized, doubleblind, placebo-controlled, crossover study design.
Methods

Subjects
We studied 10 healthy male subjects aged 31 ± 5 years, weight 77±9 kg, height 177±1 cm and body mass index 24 ± 3 kg m -2 (mean ± s.d.). All experimental procedures and protocols conformed to the Declaration of Helsinki and received local ethics committee approval. Each subject provided informed written consent before participation. No subject had a history or symptoms of cardiovascular, pulmonary, metabolic or neurological disease, hypercholesterolaemia (total cholesterol 4.6 ± 1.3 mmol l À1 ) or hypertension (X140/90 mm Hg). Cigarette smokers and those taking medications were excluded, and no subject participated in regular vigorous exercise.
Subjects were asked to refrain from consuming food and caffeine for 8 h and avoid strenuous exercise for at least 48 h preceding experimental sessions.
General experimental measurements
Brachial artery BP was measured in the nondominant arm using an aneroid sphygmomanometer (Accoson, Essex, UK). During all measurements the sphygmomanometer was in level with the subject's heart, with the arm relaxed but supported. Pulse pressure was calculated as systolic BP minus diastolic BP. A standard three-lead electrocardiogram was used to measure heart rate (HR) continuously during baseline, exercise and recovery periods. Beat-to-beat stroke volume (SV) was continuously measured using a noninvasive bio-impedance monitor (Task Force Monitor; CNSystems Medizintechnik AG, Graz, Austria). 23 The monitor sampled at a rate of 1000 Hz. Cardiac output (CO) was calculated as SV Â HR, and is reported for rest and recovery periods but not during exercise because of movement artifacts in the impedance signal.
Measures of arterial function Peripheral PWV. Femoral-to-tibial PWV was noninvasively measured using an automated oscillometric device (time resolution ± 2 ms; QVL P84, SciMed, Bristol, UK) 10 using a method developed to identify waveforms by their early phase to improve wave recognition and timing. This technique has been shown to give within-day reproducibility (minto-min variation) of 2.2% and between-day reproducibility (10 min averaged) of 5.6%. 10 Nonocclusive cuffs were placed over the mid-thigh (femoral) and ankle (tibial), and connected to computerized pressure transducers by noncompliant tubing. Cuffs were inflated to 65-70 mm Hg and pulse pressure waveforms caused by volume displacement were obtained from each of the four cuffs. A customized computer program was used to characterize the waveforms with respect to time at 30, 40 and 50% of peak pressure in their ascending phase. Ectopic beats and abnormally shaped waveforms were discarded by the computer program. The transit times between the cuffs was calculated from an average of the three points (30, 40 and 50%) of 10 continuous waveforms. Femoral PWV was then calculated by dividing the distance between the proximal points of each cuff (m) by the pulse transit time (s).
Aortic PWV. Aortic PWV was determined by applanation tonometry using a Millar piezo-resistive pressure transducer (Millar SPT 301, Millar Instruments, Houston, TX, USA) coupled to a SphygmoCor device (AtCor Medical, Sydney, Australia) and computer with dedicated software (SCOR 2000, Version 7.0, AtCor Medical). Aortic PWV was calculated by sequential acquisition of the pressure waveforms from the carotid and femoral arteries. The timing of these waveforms was matched with that of the R wave on a simultaneously recorded electrocardiogram. The distance between the recording sites at the carotid and femoral arteries was measured with a tape over the surface of the body. Aortic PWV was calculated as the carotid to femoral path length divided by the time delay between the rapid upstroke of the feet of simultaneously recorded waveforms obtained from the carotid and femoral arteries, and expressed in metres per second. 24 A BP-independent assessment of aortic distensibility (Cp) was calculated using the method of Lehmann et al.
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Pulse wave analysis. Radial artery pressure waveforms were acquired and central pressure waveforms were generated using pulse wave analysis (SphygmoCor, AtCor Medical). The central waveform was used to derive the central aortic BP, HR-corrected augmentation index. 26 The pulse wave analysis transfer function used has been validated at rest and under differing haemodynamic states, such as low-level exercise.
27,28
Calculated indices of arterial function. Total peripheral resistance, an index of the static component of arterial load, was calculated as mean arterial pressure (diastolic BP þ 1/3 pulse pressure) divided by CO. Arterial compliance, an index of the pulsatile component of arterial load, was calculated as SV divided by the pulse pressure. 29 Effective arterial elastance, an index of arterial load that incorporates both static and pulsatile components, was calculated as central end-systolic pressure (obtained from the aortic pressure waveform) divided by SV. 30 Experimental protocol A randomized, double-blind, placebo-controlled, crossover trial was performed to assess the haemodynamic and vascular responses of NO synthesis inhibition at rest during a maximal incremental exercise test and during the immediate postexercise recovery period. Studies were carried out in a temperature-controlled environment (23-25 1C) . All subjects carried out a familiarization visit to help ensure the reproducibility of subsequent repeated tests. Subjects then returned to the laboratory for two experimental sessions separated by B7 days, which were identical apart from the nature of the infusion (that is, L-NMMA or vehicle). After instrumentation for the assessment of haemodynamic and arterial function, a 14-gauge catheter was inserted into a forearm vein of the left arm while subjects were in the supine position. Subjects then rested quietly for 15 min, after which a 10 min of baseline measurement period was conducted. A bolus infusion was then administered for 5 min, which was followed by a 10-min post-infusion measurement period. Subjects then performed a maximal incremental exercise test on an upright stationary cycle ergometer (874E; Monark Exercise AB, Varberg, Sweden). Immediately after this, subjects were returned to the supine position for a 15-min postexercise recovery period. BP and HR were measured throughout the experimental protocol, but recordings of arterial function were omitted during the maximal exercise test because of the sensitive nature of these measurements. Peripheral PWV measurements were made each minute, whereas aortic PWV and central pulse wave analysis measures were made every 2 min before and after exercise.
Infusions
After completion of baseline measurements, each subject received an initial bolus infusion of L-NMMA, 3 Figure 1 shows measures of arterial stiffness (aortic and femoral PWV, augmentation index and Cp) at baseline and following the maximal exercise test after infusion of saline or L-NMMA. No difference in any measure of arterial stiffness was observed at baseline. After infusion of L-NMMA, augmentation index was significantly increased (Po0.05 vs baseline), whereas femoral PWV was not significantly changed. With L-NMMA infusion, Exercise-induced hypertension: role of NO R Campbell et al aortic PWV tended to increase and Cp tended to decrease, although these changes did not reach statistical significance. During recovery from maximal incremental exercise, aortic PWV was elevated above baseline levels, whereas Cp was significantly reduced at the mid and late recovery time points in both the saline and L-NMMA conditions (Po0.05 vs baseline, P40.05, saline vs L-NMMA). In contrast, with saline, femoral PWV was decreased from baseline during all phases of the recovery period (early, mid and late; Po0.05), but this reduction in femoral PWV was not observed in the L-NMMA condition (P40.05 vs baseline). After exercise, augmentation index was significantly reduced for the duration of the recovery period in both the saline and L-NMMA conditions (Po0.05 vs after infusion, P40.05 vs between conditions). Figure 2 shows indices of arterial load at baseline and following graded incremental maximal exercise after infusion of saline or L-NMMA. Arterial elastance was increased with L-NMMA infusion at rest (P ¼ 0.05 vs baseline), and remained elevated at that level throughout the recovery period (Po0.05 vs baseline, P40.05 vs after infusion). However, in the saline condition, arterial elastance was unchanged from baseline throughout the recovery period. Total peripheral resistance was increased by L-NMMA infusion at rest (Po0.05), and was reduced during all phases of the recovery period, with no differences between saline and L-NMMA conditions (P40.05). Arterial compliance was unchanged with infusion of L-NMMA (P40.05 vs baseline), and was reduced similarly after exercise in the saline and L-NMMA conditions (Po0.05 vs baseline, P40.05 vs between conditions).
Discussion
An exaggerated BP response to exercise is associated with an increased cardiovascular risk, even in individuals who are apparently normotensive at rest. [2] [3] [4] [5] [6] This study examined the effects of inhibition of NO synthesis on BP responses to incremental leg cycling exercise, VO 2 max, and central and peripheral arterial stiffness during exercise recovery. The major novel findings of this study are that pharmacological inhibition of NO synthase with intravenous administration of L-NMMA increases BP during sub-maximal exercise, but does not cause an exaggerated BP response to maximal exercise or reduce VO 2 max. Furthermore, NO is an important contributor to postmaximal exercise reductions in femoral artery stiffness in healthy individuals, whereas aortic stiffness seems to be increased from rest after maximal exercise, irrespective of NO inhibition. These findings suggest that whereas NO partly mediates exercise-induced increases in arterial distensibility, the influence of NO on the hypertensive response to exercise is intensity dependent. Exercise-induced hypertension: role of NOAn exaggerated BP response to exercise may be related to an impaired vascular adaptation to the exercise-induced increases in CO, because of reductions in vascular NO. Indeed, exaggerated BP responses to exercise are associated with impaired endothelial-dependent vasodilatation at rest [14] [15] [16] and attenuated increases in serum cyclic guanosine monophosphate concentrations during exercise, 35 whereas subjects with exaggerated BP responses to exercise are known to have an impaired capacity for exercise-induced decreases in systemic vascular resistance. 17 Furthermore, both this study and previous work 13 suggest that resting arterial stiffness is increased with inhibition of NO synthase, whereas elevations in arterial stiffness may augment the BP responses to exercise. 8 Given these associative findings, it is possible that elevations in arterial stiffness and impairments in vascular regulation during exercise, because of reductions in NO, are an important determinant of the magnitude of the exercise-induced BP response. Importantly, we observed that the acute inhibition of NO with L-NMMA, previously shown to impair endothelialdependent vasodilatation 36 and reduce serum cyclic guanosine monophosphate concentration 37 in healthy individuals, significantly increased the BP responses to sub-maximal exercise. However, intriguingly, L-NMMA had no effect on BP responses to maximal exercise. The reason for the exercise intensity-dependent influence of NO inhibition on BP responsiveness is presently unclear. However, it may be that protective regulatory mechanisms, such as the arterial baroreflex, become particularly important in buffering the very high BP observed during maximal exercise. Nevertheless, the differential effects of NO on the BP responses to maximal and sub-maximal exercise may have clinical and physiological relevance. Indeed, it is often maximal BP in particular that has been related to increased cardiovascular risk 2, 4, 6 and with resting endothelial dysfunction. 14, 15, 35 Hence, it may be that impairments in endothelial function are related to BP responses to maximal exercise because of concomitant dysregulation in other mechanisms implicated in the control of the vasculature and BP during exercise (for example, impaired baroreflex function, attenuated metabolic vasodilatation, upregulation of endothelial-derived vasoconstrictors, increased circulating vasoconstrictors and exaggerated neural sympathetic vasoconstriction).
After maximal exercise with saline, femoral PWV was markedly reduced throughout the postmaximal exercise recovery period (that is, decreased femoral artery stiffness), in agreement with previous works from us 10 and others. 11, 12 Notably, this reduction in femoral artery stiffness was significantly attenuated with L-NMMA, thus implying that the acute postmaximal exercise reduction in femoral artery stiffness (p15 min) is at least partially mediated by NO. In contrast to this reduction in femoral PWV, aortic PWV was increased immediately after maximal exercise (that is, increased central arterial stiffness). The observed failure of the aorta to augment its distensibility after maximal exercise, unlike the peripheral arteries, was unexpected. Indeed, it has previously been shown that aortic stiffness is reduced after sub-maximal cycling exercise. 11 The mechanisms underlying this exercise intensitydependent effect are unclear, although differences Exercise-induced hypertension: role of NOin HR and BP between these studies may contribute to this apparent difference. 38 Nevertheless this observation highlights the fact that caution must taken in generalizing the effects of exercise on arterial function without consideration of exercise intensity.
Along with increasing central arterial stiffness (that is, increased aortic PWV), we observed that blockade of NO with L-NMMA caused an increase in resting arterial elastance. Such increases in arterial elastance in exercising dogs have been shown to exacerbate rises in systolic BP and impose additional energetic demands on the heart, which may potentially reduce cardiac reserve. 18, 19 However, the changes in resting arterial elastance observed in this study failed to augment exercise-induced increases in BP or reduce maximal exercise capacity. Similarly, previous work with methionine loading, which also impairs resting endothelial function, does not influence maximal exercise capacity in humans. 39 An additional consequence of L-NMMA administration is the removal of the beneficial effects of NO directly on the ventricles that would influence the SV response to exercise. Indeed, NO has significant lusitropic effects, 20 which have recently been shown to be attributable to protein kinase G-mediated phosphorylation of titin. 40 This effect is likely to become particularly important for maintenance of diastolic volume at high HR, such as that induced by exercise. Indeed, NOS inhibition with L-NMMA has been shown to increase myocardial stiffness and impair the preload-induced augmentation of diastolic filling and CO. 41, 42 Thus, we reasoned that in exercising humans, L-NMMAmediated blockade of ventricular NO could cause a preload-dependent impairment of CO, consequently reducing maximal aerobic capacity. However, no performance-related measure of exercise capacity was affected by NO blockade (for example, VO 2 max and time to peak exercise).
Interestingly, the recovery of HR during the immediate postexercise period was similar in the saline and L-NMMA conditions. The immediate recovery of HR from exercise has been attributed to the rapid reactivation of parasympathetic tone, 43 and notably impairments in HR recovery have been linked with mortality and cardiovascular prognosis. 44 In light of recent work showing that neuronal NO modulates parasympathetic tone by increasing acetylcholine release, 45 one might have expected that parasympathetic reactivation, and hence HR recovery, would have been more sluggish with L-NMMA. However, our observation that L-NMMA does not influence immediate postexercise HR recovery may suggest that NO does not have a significant role in the modulation of parasympathetic nervous system at this time in young healthy individuals.
A limitation of this study is that a single dosage of L-NMMA was used. However, the L-NMMA dosage used in the present investigation is similar to that used in several previous studies performed both at rest [46] [47] [48] and during exercise. 31, 49, 50 Furthermore, it has been shown to significantly reduce serum concentrations of cyclic guanosine monophosphate 37 and NO, 46 inhibit vasodilatation by acetylcholine 51 and induce endothelial dysfunction. 36 Although the efficacy of the L-NMMA administration in reducing the production of NO was not assessed in this study, the magnitude of the BPraising effect of L-NMMA observed at rest is similar to that previously reported. 46, 48, 52 Furthermore, it is unlikely that an exercise-induced increase in NO production could overcome blockade by L-NMMA, as it has been reported that when NO synthase is stimulated by agonists (for example, acetylcholine), the proportion of the response blocked by L-NMMA increases with increasing stimulation. 50, 53 A higher dosage of L-NMMA was not used in this study because of the potentially confounding effects of reductions of NO within the central nervous system and subsequent increases in central sympathetic vasoconstrictor outflow. 54 However, we cannot exclude the possibility that inhibition of NO synthase enhanced the production of compensatory endothelial-derived relaxing factors, for example, prostacyclin, 55 which subsequently influenced endothelial function and arterial stiffness during this study.
An exaggerated BP response to exercise is associated with an increased cardiovascular risk even in individuals who are apparently normotensive at rest. [2] [3] [4] [5] [6] This altered haemodynamic response to exercise has been linked with endothelial dysfunction and increased arterial stiffness. 14, 15, 35 Our findings are the first to show that pharmacological inhibition of NO synthesis causes an exaggerated BP response to sub-maximal exercise, but does not elicit an exaggerated BP response to maximal exercise or reduce maximal exercise capacity.
What is known about topic K An exaggerated blood pressure response to exercise is associated with an increased risk of future hypertension, stroke and cardiovascular mortality in normotensive individuals. K Endothelial dysfunction and elevated arterial stiffness may contribute to exercise-induced hypertension, but the underlying mechanisms remain unclear. K Reduced nitric oxide (NO) is associated with vascular dysfunction.
What this study adds K We demonstrate that NO is an important contributor to exercise-induced reductions in femoral artery stiffness after maximal exercise stress testing. K This is the first study showing that pharmacological inhibition of NO synthesis can augment the blood pressure response to sub-maximal exercise, but not maximal exercise, suggesting that the influence of NO on the hypertensive response to exercise is intensity dependent.
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